54.75
Bright Minds Biosciences Inc stock is traded at $54.75, with a volume of 124.62K.
It is up +0.51% in the last 24 hours and down -9.74% over the past month.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
See More
Previous Close:
$54.47
Open:
$54.41
24h Volume:
124.62K
Relative Volume:
1.26
Market Cap:
$385.66M
Revenue:
-
Net Income/Loss:
$-4.98M
P/E Ratio:
-41.55
EPS:
-1.3177
Net Cash Flow:
$-3.85M
1W Performance:
-10.51%
1M Performance:
-9.74%
6M Performance:
+78.34%
1Y Performance:
+16.99%
Bright Minds Biosciences Inc Stock (DRUG) Company Profile
Name
Bright Minds Biosciences Inc
Sector
Industry
Phone
-
Address
-
Compare DRUG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
DRUG
Bright Minds Biosciences Inc
|
54.75 | 386.12M | 0 | -4.98M | -3.85M | -1.3177 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Bright Minds Biosciences Inc Stock (DRUG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-08-25 | Initiated | BTIG Research | Buy |
| May-13-25 | Initiated | TD Cowen | Buy |
| May-07-25 | Initiated | Chardan Capital Markets | Buy |
| Jan-23-25 | Initiated | Piper Sandler | Overweight |
| Jan-10-25 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-10-25 | Initiated | H.C. Wainwright | Buy |
| Nov-26-24 | Initiated | Robert W. Baird | Outperform |
View All
Bright Minds Biosciences Inc Stock (DRUG) Latest News
Will Bright Minds Biosciences Inc. stock attract ESG investors2025 Top Decliners & Technical Confirmation Trade Alerts - newser.com
Building trade automation scripts for Bright Minds Biosciences Inc.Market Growth Review & Consistent Profit Focused Trading Strategies - newser.com
Is Bright Minds Biosciences Inc. a candidate for recovery play2025 Market Overview & Consistent Income Trade Ideas - newser.com
Real time breakdown of Bright Minds Biosciences Inc. stock performance2025 Performance Recap & High Accuracy Trade Alerts - newser.com
What’s next for Bright Minds Biosciences Inc. stock priceJuly 2025 Gainers & Technical Entry and Exit Tips - newser.com
A activityEarnings Performance Report & Weekly High Return Stock Opportunities - newser.com
Does Bright Minds Biosciences Inc. qualify in momentum factor screeningQuarterly Profit Summary & Real-Time Buy Zone Alerts - newser.com
Pattern recognition hints at Bright Minds Biosciences Inc. upsideExit Point & Consistent Return Investment Signals - newser.com
What machine learning models say about Bright Minds Biosciences Inc.Weekly Profit Analysis & Smart Allocation Stock Reports - newser.com
Identifying reversal signals in Bright Minds Biosciences Inc.2025 Market Outlook & Daily Profit Maximizing Trade Tips - newser.com
Is Bright Minds Biosciences Inc. stock a safe investment in uncertain marketsJuly 2025 Snapshot & Reliable Entry Point Trade Alerts - newser.com
Using data models to predict Bright Minds Biosciences Inc. stock movementPortfolio Gains Report & Daily Technical Forecast Reports - newser.com
Bright Minds Biosciences Inc. stock prediction for this weekWeekly Stock Report & Precise Buy Zone Identification - newser.com
Is Bright Minds Biosciences Inc. stock a good choice for value investorsWeekly Stock Recap & Verified Entry Point Signals - newser.com
Bright Minds Biosciences Inc Stock Analysis and ForecastDividend Stock Watch & Get Trading Help From Experienced Users - earlytimes.in
Developing predictive dashboards with Bright Minds Biosciences Inc. dataPortfolio Value Report & Daily Technical Stock Forecast Reports - newser.com
Bright Minds Biosciences Inc. (DRUG) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Bright Minds Biosciences to Present at Upcoming Conferences - The Manila Times
Bright Minds (NASDAQ: DRUG) to present at Guggenheim, Jefferies; 60-day webcast replay - Stock Titan
Published on: 2025-10-30 00:39:56 - newser.com
Bright Minds Biosciences Advances Epilepsy Treatment with BMB-101 Study - TipRanks
What is Bright Minds Biosciences Inc (DRUG) Price Targets? - fostersleader.com
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
Bright Minds Biosciences Inc Stock (DRUG) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):